Figure legends from Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention

Authors:

Abstract
Legends for Supplementary Figure S1 & Supplementary Figure S2